secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001759425-25-000034
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Mirum Pharmaceuticals 2025 Annual Meeting results: three directors elected
--------------------------------------------------------------------------

- Class III directors elected: Laura Brege (17.97M for, 18.17M withheld), Michael Grey (30.78M for), Christopher Peetz (35.98M for).
- Ratified Ernst & Young as independent auditor for FY2025: 43.12M for, 19.2K against, 19.4K abstentions.
- Advisory vote on executive compensation approved: 34.67M for, 1.46M against, 8.9K abstentions.
- Broker non-votes of 7.02M on director elections and compensation proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000175942525000034/0001759425-25-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000175942525000034/mirm-20250529.htm
  HTML page:      https://secwatch.observer/filing/0001759425-25-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer